An officer proposes selling 124,042 shares of Dianthus Therapeutics (DNTH).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Dianthus Therapeutics officer Ryan Savitz has filed a notice for the proposed sale of 124,042 common shares, valued at Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context